Kelly Fleetwood

891 total citations
38 papers, 600 citations indexed

About

Kelly Fleetwood is a scholar working on Epidemiology, Psychiatry and Mental health and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Kelly Fleetwood has authored 38 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 8 papers in Psychiatry and Mental health and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Kelly Fleetwood's work include Chronic Disease Management Strategies (10 papers), Schizophrenia research and treatment (7 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Kelly Fleetwood is often cited by papers focused on Chronic Disease Management Strategies (10 papers), Schizophrenia research and treatment (7 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Kelly Fleetwood collaborates with scholars based in United Kingdom, United States and Denmark. Kelly Fleetwood's co-authors include Rachael McCool, Sarah H. Wild, Mick Arber, Caroline Jackson, Julie Glanville, Daniel J. Smıth, Stewart W Mercer, Susan Edwards, Michael J. Raschke and D. Franz and has published in prestigious journals such as Diabetes Care, The British Journal of Psychiatry and Diabetologia.

In The Last Decade

Kelly Fleetwood

31 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelly Fleetwood United Kingdom 15 159 123 105 85 81 38 600
Anju Jain India 15 109 0.7× 84 0.7× 111 1.1× 26 0.3× 58 0.7× 50 584
Efthimios Deligeoroglou Greece 22 114 0.7× 88 0.7× 94 0.9× 27 0.3× 81 1.0× 73 1.3k
Refik Burgut Türkiye 18 280 1.8× 123 1.0× 51 0.5× 100 1.2× 36 0.4× 52 892
Seung Ki Min South Korea 12 143 0.9× 130 1.1× 97 0.9× 117 1.4× 93 1.1× 48 618
Nasir A.M. Al-Jurayyan Saudi Arabia 14 72 0.5× 122 1.0× 139 1.3× 36 0.4× 41 0.5× 46 574
Mehmet Türkmen Türkiye 16 111 0.7× 169 1.4× 25 0.2× 202 2.4× 54 0.7× 103 958
Sara Lenherr United States 18 207 1.3× 138 1.1× 60 0.6× 70 0.8× 318 3.9× 56 911
Henning Schneider Germany 15 55 0.3× 137 1.1× 71 0.7× 99 1.2× 201 2.5× 42 666
S P Chan Singapore 13 160 1.0× 91 0.7× 58 0.6× 196 2.3× 329 4.1× 20 752
Shmuel Segal Israel 19 56 0.4× 195 1.6× 138 1.3× 72 0.8× 50 0.6× 50 1.2k

Countries citing papers authored by Kelly Fleetwood

Since Specialization
Citations

This map shows the geographic impact of Kelly Fleetwood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Fleetwood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Fleetwood more than expected).

Fields of papers citing papers by Kelly Fleetwood

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Fleetwood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Fleetwood. The network helps show where Kelly Fleetwood may publish in the future.

Co-authorship network of co-authors of Kelly Fleetwood

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Fleetwood. A scholar is included among the top collaborators of Kelly Fleetwood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Fleetwood. Kelly Fleetwood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fleetwood, Kelly, Caroline Jackson, Stewart W Mercer, et al.. (2025). Robustly measuring multimorbidity using disparate linked datasets. Communications Medicine. 5(1). 283–283.
2.
Fleetwood, Kelly, Bruce Guthrie, Caroline Jackson, et al.. (2025). Depression and physical multimorbidity: A cohort study of physical health condition accrual in UK Biobank. PLoS Medicine. 22(2). e1004532–e1004532. 9 indexed citations
3.
4.
5.
Fleetwood, Kelly, et al.. (2025). Cancer Incidence Among People With a Prior Hospital Record of Depression in Scotland, 1991–2019: A Cohort Study. Cancer Medicine. 14(1). e70496–e70496. 1 indexed citations
6.
Fleetwood, Kelly, et al.. (2024). Ethnic disparities in quality of diabetes care in Scotland: A national cohort study. Diabetic Medicine. 41(9). e15336–e15336.
7.
Fleetwood, Kelly, et al.. (2023). Severe Mental Illness and Type 2 Diabetes Outcomes and Complications: A Nationwide Cohort Study. Diabetes Care. 46(7). 1363–1371. 15 indexed citations
8.
McCool, Rachael, et al.. (2019). Systematic review and network meta-analysis comparing ocrelizumab with other treatments for relapsing multiple sclerosis. Multiple Sclerosis and Related Disorders. 29. 55–61. 66 indexed citations
9.
10.
McCool, Rachael, Ian M. Gould, Mick Arber, et al.. (2017). Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA. BMC Infectious Diseases. 17(1). 39–39. 27 indexed citations
11.
Fleetwood, Kelly, Julie Glanville, Rachael McCool, et al.. (2016). A Review of the Use of Network Meta-Analysis In Nice Single Technology Appraisals. Value in Health. 19(7). A348–A348. 5 indexed citations
12.
Claxton, Lindsay, et al.. (2016). The Cost-Effectiveness of Ranibizumab Treat and Extend Regimen Versus Aflibercept in the UK. Advances in Therapy. 33(9). 1660–1676. 14 indexed citations
13.
Fleetwood, Kelly, et al.. (2015). Alternatives To Winbugs for Network Meta–Analysis. Value in Health. 18(7). A720–A720. 16 indexed citations
14.
15.
Perry, Rachel, et al.. (2014). Estimating Survival Data from Published Kaplan-Meier Curves: a Comparison of Methods. Value in Health. 17(7). A326–A326. 5 indexed citations
16.
Craig, Joyce, Thomas Fuchs, Michelle Jenks, et al.. (2014). Systematic review and meta-analysis of the additional benefit of local prophylactic antibiotic therapy for infection rates in open tibia fractures treated with intramedullary nailing. International Orthopaedics. 38(5). 1025–1030. 85 indexed citations
17.
Bachelot, Thomas, Rachael McCool, Steven Duffy, et al.. (2013). Comparative efficacy of everolimus plus exemestane versus fulvestrant for hormone-receptor-positive advanced breast cancer following progression/recurrence after endocrine therapy: a network meta-analysis. Breast Cancer Research and Treatment. 143(1). 125–133. 25 indexed citations
18.
Taylor, Matthew, et al.. (2013). The Use of Data from Published Kaplan-Meier Survival Curves in NICE HTAs. Value in Health. 16(7). A594–A594. 2 indexed citations
19.
Watkinson, Allan, Ashok Ganesan, Kelly Fleetwood, et al.. (2013). Increasing the Potency of an Alhydrogel-Formulated Anthrax Vaccine by Minimizing Antigen-Adjuvant Interactions. Clinical and Vaccine Immunology. 20(11). 1659–1668. 25 indexed citations
20.
Bulmer, Michael & Kelly Fleetwood. (2003). Estimation issues in allometric scaling models. Queensland's institutional digital repository (The University of Queensland). 4. 1973–1978. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anju Jain Breakdown of academic impact, for papers by Efthimios Deligeoroglou Breakdown of academic impact, for papers by Refik Burgut Breakdown of academic impact, for papers by Seung Ki Min Breakdown of academic impact, for papers by Nasir A.M. Al-Jurayyan Breakdown of academic impact, for papers by Mehmet Türkmen Breakdown of academic impact, for papers by Sara Lenherr Breakdown of academic impact, for papers by Henning Schneider Breakdown of academic impact, for papers by S P Chan Breakdown of academic impact, for papers by Shmuel Segal
Rankless by CCL
2026